Ordinary Rebalance | Solactive China Biotech Innovation Index | Effective Date 14th November 2022
In the ordinary rebalancing the following index composition will be implemented effective open 14.11.2022:
| 3SBIO INC |
| ALPHAMAB ONCOLOGY |
| BEIJING BOHUI INNOVATION B-A |
| BEIJING SL PHARMACEUTICAL -A |
| BEIJING TIANTAN BIOLOGICAL-A |
| BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO LTD |
| BERRY GENOMICS CO LTD-A |
| BGI GENOMICS CO LTD-A |
| CANSINO BIOLOGICS INC |
| CHANGCHUN HIGH & NEW TECH-A |
| CHENGDU KANGHUA BIOLOGICAL PRODUCTS CO LTD |
| CHONGQING ZHIFEI BIOLOGICA-A |
| CSPC PHARMACEUTICAL GROUP LTD |
| DAAN GENE CO LTD-A |
| GENSCRIPT BIOTECH CORP |
| GETEIN BIOTECH INC-A |
| GUANGZHOU WONDFO BIOTECH C-A |
| HEBEI CHANGSHAN BIOCHEMICA-A |
| HUALAN BIOLOGICAL ENGINEER-A |
| JOINN LABORATORIES CHINA CO LTD |
| KINTOR PHARMACEUTICAL LTD |
| PACIFIC SHUANGLIN BIO-PHARMACY |
| SHANGHAI RAAS BLOOD PRODUC-A |
| SHANGHAI ZJ BIO-TECH CO LT-A |
| SHENZHEN KANGTAI BIOLOGICA-A |
| SICHUAN KELUN PHARMACEUTIC-A |
| WALVAX BIOTECHNOLOGY CO-A |
| WUHAN KEQIAN BIOLOGY CO LT-A |
| WUXI BIOLOGICS CAYMAN INC |
| ZAI LAB LTD |